Market Place
Sourcing Support
Sanofi Sells Generics Unit To Brazil`s EMS
06 Mar 2026 //
PRESS RELEASE
Earendil Labs Announces Strategic Collaboration with Sanofi
06 Jan 2026 //
PR NEWSWIRE
Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
12 Jul 2025 //
REUTERS
Viz.ai Collaborates With Sanofi and Regeneron on COPD Care
21 May 2025 //
PRESS RELEASE
Sarclisa Approved In EU As 1st Anti-CD38 For Multiple Myeloma
22 Jan 2025 //
PRESS RELEASE
First trial over Zantac cancer claims set to begin in Chicago
01 May 2024 //
REUTERS
Sanofi Q1 profit slips on generic competition, forex effects
25 Apr 2024 //
REUTERS
Sandoz presents compelling investment proposition as standalone company
08 Jun 2023 //
PRESS RELEASE
Phase 3 data presented at WORLDSymposium reinforce Nexviazyme as standard of care
24 Feb 2023 //
GLOBENEWSWIRE
Novartis sues FDA, claiming Sanofi`s Aubagio isn`t really new
12 Mar 2021 //
FIERCE PHARMA
Amgen v. Sanofi Praulent® Litigation Once Again on Appeal
15 Apr 2020 //
BIGMOLECULEWATCH
After Zantac scare, FDA targets generic metformin for carcinogen tests
07 Dec 2019 //
FIERCE PHARMA
EY vet set to replace retiring Amgen CFO Meline
23 Oct 2019 //
ENDPTS
Zantac maker Sanofi joins peers in recalling antacid
22 Oct 2019 //
FIERCE PHARMA
Novo Nordisk rolls out authorized insulin generics
07 Sep 2019 //
FIERCEPHARMA
Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC
29 Aug 2019 //
PATENT DOCS
Sanofi patent case win holds off generic rivals for key cancer drug
16 Aug 2019 //
PMLIVE
Sanofi defends top oncology drug with Jevtana patent win
16 Aug 2019 //
FIERCE PHARMA
The top 10 all-time biggest-selling drugs by 2024
15 Aug 2019 //
FIERCE PHARMA
Will Novo and Sanofi follow Lilly`s generic Humalog move?
07 Mar 2019 //
FIERCE PHARMA
Insulin has become so expensive that this diabetic is trying to make his own
28 Jan 2019 //
CNBC
Supreme Court Denies Certiorari in Amgen v. Sanofi
17 Jan 2019 //
PATENT DOCS
Sanofi`s Formulation Patents on Lantus Invalidated by USPTO, Announces Mylan
22 Dec 2018 //
PR NEWSWIRE
Mylan says patent office cancels Sanofi`s Lantus patents
14 Dec 2018 //
REUTERS
Mylan says patent office cancels Sanofi`s Lantus patents
14 Dec 2018 //
REUTERS
Jardiance (empagliflozin) : Boehringer Ingelheim vs. Zydus Pharms
20 Nov 2018 //
PATENT LITIGATION
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Sun Pharma
01 Nov 2018 //
PATENT LITIGATION
Pomalyst (Pomalidomide) : Celgene Corp. vs. Breckenridge Pharma
19 Oct 2018 //
PATENT LITIGATION
Sanofi bets big on India
29 Aug 2018 //
MANUFACTURING CHEMIST
Sanofi, Advent finally shake hands on $2.2B European generics sale
29 Jun 2018 //
FIERCE PHARMA
UK bans Sanofi epilepsy drug without pregnancy prevention plan
25 Apr 2018 //
REUTERS
Sanofi, Advent near €2B deal for Zentiva: report
17 Apr 2018 //
FIERCE PHARMA
Torrent drops out of Sanofi EU generics auction over price: report
06 Apr 2018 //
FIERCE PHARMA
Torrent Pharma may raise Rs1,500 crore in bid for Sanofi generics business
13 Mar 2018 //
LIVEMINT
Generics, mergers and Teva’s woes: Agilent talks pharma opportunities
16 Feb 2018 //
IN PHARMATECHNOLOGIST
Sanofi EU generics biz sale narrows to 2 drugmakers: Reuters
07 Feb 2018 //
FIERCE PHARMA
Brazil`s EMS and India`s Torrent Pharma vying for Sanofi`s generic drugs
06 Feb 2018 //
REUTERS
Sanofi CEO: $16 Billion Deal Binge Does Not Represent A Change In Strategy
31 Jan 2018 //
FORBES
Intas puts the fizz back into ex-Sanofi plant with generic effervescents
31 Jan 2018 //
IN PHARMATECHNOLOGIST
Indian pharma majors weigh bids for Sanofi’s $2 billion EU generics business
10 Jan 2018 //
ECONOMIC TIMES
Pharma`s unit sales and spins are back in style
20 Dec 2017 //
FIERCE PHARMA
Novartis looks at offloading its generic pills business in U.S.
05 Dec 2017 //
FIERCE PHARMA
Impax Labs shares rise on FDA approval of generic Renvela
23 Oct 2017 //
MARKETWATCH
At least six funds interested in Sanofi European generic drugs unit -Le Figaro
07 Oct 2017 //
REUTERS
Sanofi Wins False Claims Case Appealed by Rival Drugmaker
18 May 2017 //
BNA
Dupixent (Dupilumab): Immunex v. Sanofi Genzyme, Aventisub LLC, & Regeneron
05 Apr 2017 //
PATENT LITIGATION
Thwarted buyer Sanofi tries its hand at a $2.1B European generics sale: report
09 Mar 2017 //
FIERCE PHARMA
Sanofi Looking to Slap `For Sale` Sign on Its EU Generic Drug, Deal $2.1 Billion
08 Mar 2017 //
BIOSPACE
Impax Confirms Patent Challenge Relating to Generic Aubagio Tablets
07 Jan 2017 //
PR NEWSWIRE
The Top 100 Manufacturers Of Generic Pharmaceuticals Worldwide
16 Dec 2016 //
PR NEWSWIRE
Sanofi Plants in Czech Republic and Romania will be Part of Generics Sale
17 Nov 2016 //
FIERCE PHARMA
Sanofi having difficulty deciding how, or even if, to divest EU generics biz
02 Mar 2016 //
FIERCE PHARMA
EpiPen set to lose $800M in sales by 2018
09 Jan 2016 //
FIERCE PHARMA
Sanofi Puts Merial Animal Business, Generics Unit on Review
05 Nov 2015 //
BLOOMBERG
Sanofi Announces Launch of Authorized Generic Version of Arava® Tablets
01 Oct 2015 //
PR NEWS WIRE
Despite Generic Erosion of Current Market, Asthma Market Will Remain Steady
22 Sep 2015 //
PR NEWS WIRE
Lilly and Boehringer launch Lantus biosimilar in UK
26 Aug 2015 //
PM LIVE
Sanofi and Evotec align forces to develop next generation therapies in diabetes
06 Aug 2015 //
EVOTEC
Sanofi`s Lixilan Hits Phase III Goal
29 Jul 2015 //
BIOSPACE
Sanofi dengue vaccine shows promise in older children
28 Jul 2015 //
PHARMA TIMES
